338 related articles for article (PubMed ID: 17517932)
1. Comparison of delayed enhanced CT and chemical shift MR for evaluating hyperattenuating incidental adrenal masses.
Park BK; Kim CK; Kim B; Lee JH
Radiology; 2007 Jun; 243(3):760-5. PubMed ID: 17517932
[TBL] [Abstract][Full Text] [Related]
2. MR imaging of adrenal masses: value of chemical-shift imaging for distinguishing adenomas from other tumors.
Bilbey JH; McLoughlin RF; Kurkjian PS; Wilkins GE; Chan NH; Schmidt N; Singer J
AJR Am J Roentgenol; 1995 Mar; 164(3):637-42. PubMed ID: 7863885
[TBL] [Abstract][Full Text] [Related]
3. Adenoma characterization: adrenal protocol with dual-energy CT.
Kim YK; Park BK; Kim CK; Park SY
Radiology; 2013 Apr; 267(1):155-63. PubMed ID: 23329655
[TBL] [Abstract][Full Text] [Related]
4. The value of 15-minute delayed contrast-enhanced CT to differentiate hyperattenuating adrenal masses compared with chemical shift MR imaging.
Koo HJ; Choi HJ; Kim HJ; Kim SO; Cho KS
Eur Radiol; 2014 Jun; 24(6):1410-20. PubMed ID: 24647823
[TBL] [Abstract][Full Text] [Related]
5. Comparison of unenhanced CT and chemical shift MRI in evaluating lipid-rich adrenal adenomas.
Israel GM; Korobkin M; Wang C; Hecht EN; Krinsky GA
AJR Am J Roentgenol; 2004 Jul; 183(1):215-9. PubMed ID: 15208141
[TBL] [Abstract][Full Text] [Related]
6. Chemical shift MR imaging of hyperattenuating (>10 HU) adrenal masses: does it still have a role?
Haider MA; Ghai S; Jhaveri K; Lockwood G
Radiology; 2004 Jun; 231(3):711-6. PubMed ID: 15118113
[TBL] [Abstract][Full Text] [Related]
7. Comparison of computed tomography histogram analysis and chemical-shift magnetic resonance imaging for adrenal mass characterization.
Halefoglu AM; Yasar A; Bas N; Ozel A; Erturk SM; Basak M
Acta Radiol; 2009 Nov; 50(9):1071-9. PubMed ID: 19863419
[TBL] [Abstract][Full Text] [Related]
8. Adrenal adenoma and metastasis from clear cell renal cell carcinoma: can they be differentiated using standard MR techniques?
Woo S; Cho JY; Kim SY; Kim SH
Acta Radiol; 2014 Nov; 55(9):1120-8. PubMed ID: 24252816
[TBL] [Abstract][Full Text] [Related]
9. Characterization of lipid-poor adrenal adenoma: chemical-shift MRI and washout CT.
Seo JM; Park BK; Park SY; Kim CK
AJR Am J Roentgenol; 2014 May; 202(5):1043-50. PubMed ID: 24758658
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of chemical-shift MR imaging to differentiate between adrenal adenomas and non adenoma adrenal lesions.
Maurea S; Imbriaco M; D'Angelillo M; Mollica C; Camera L; Salvatore M
Radiol Med; 2006 Aug; 111(5):674-86. PubMed ID: 16791464
[TBL] [Abstract][Full Text] [Related]
11. Effect of echo time pair selection on quantitative analysis for adrenal tumor characterization with in-phase and opposed-phase MR imaging: initial experience.
Schindera ST; Soher BJ; Delong DM; Dale BM; Merkle EM
Radiology; 2008 Jul; 248(1):140-7. PubMed ID: 18566172
[TBL] [Abstract][Full Text] [Related]
12. Distinguishing tumefactive demyelinating lesions from glioma or central nervous system lymphoma: added value of unenhanced CT compared with conventional contrast-enhanced MR imaging.
Kim DS; Na DG; Kim KH; Kim JH; Kim E; Yun BL; Chang KH
Radiology; 2009 May; 251(2):467-75. PubMed ID: 19261924
[TBL] [Abstract][Full Text] [Related]
13. Quantitative evaluation of norcholesterol scintigraphy, CT attenuation value, and chemical-shift MR imaging for characterizing adrenal adenomas.
Yoh T; Hosono M; Komeya Y; Im SW; Ashikaga R; Shimono T; Tsuchiya N; Okada M; Hanada K; Yagyu Y; Nishimura Y; Murakami T
Ann Nucl Med; 2008 Jul; 22(6):513-9. PubMed ID: 18670858
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of adrenal metastases from renal cell carcinoma and hepatocellular carcinoma: use of delayed contrast-enhanced CT.
Choi YA; Kim CK; Park BK; Kim B
Radiology; 2013 Feb; 266(2):514-20. PubMed ID: 23151828
[TBL] [Abstract][Full Text] [Related]
15. Chemical-shift MRI versus washout CT for characterizing adrenal incidentalomas.
Warda MH; Shehata SM; Zaiton F
Clin Imaging; 2016; 40(4):780-7. PubMed ID: 27317224
[TBL] [Abstract][Full Text] [Related]
16. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses.
Inan N; Arslan A; Akansel G; Anik Y; Balci NC; Demirci A
Eur J Radiol; 2008 Jan; 65(1):154-62. PubMed ID: 17466481
[TBL] [Abstract][Full Text] [Related]
17. Characterization of adrenal masses using MR imaging with histopathologic correlation.
Heinz-Peer G; Hönigschnabl S; Schneider B; Niederle B; Kaserer K; Lechner G
AJR Am J Roentgenol; 1999 Jul; 173(1):15-22. PubMed ID: 10397092
[TBL] [Abstract][Full Text] [Related]
18. Comparison of delayed enhanced CT and 18F-FDG PET/CT in the evaluation of adrenal masses in oncology patients.
Park BK; Kim CK; Kim B; Choi JY
J Comput Assist Tomogr; 2007; 31(4):550-6. PubMed ID: 17882030
[TBL] [Abstract][Full Text] [Related]
19. Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging.
Korobkin M; Lombardi TJ; Aisen AM; Francis IR; Quint LE; Dunnick NR; Londy F; Shapiro B; Gross MD; Thompson NW
Radiology; 1995 Nov; 197(2):411-8. PubMed ID: 7480685
[TBL] [Abstract][Full Text] [Related]
20. Incidental adrenal lesions: Accuracy of quadriphasic contrast enhanced computed tomography in distinguishing adenomas from nonadenomas.
Foti G; Faccioli N; Mantovani W; Malleo G; Manfredi R; Mucelli RP
Eur J Radiol; 2012 Aug; 81(8):1742-50. PubMed ID: 21602008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
